PCG
Pengana Capital Group Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💰 Dividends
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual growth
💰
6.60%
Annual dividend yield
Based on the most recent dividend
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
1
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Pengana Capital Group Ltd. engages in the diversified funds management business. The company is headquartered in Sydney, New South Wales. The company went IPO on 2001-02-28. The Company’s investment objective is to increase the investor wealth by developing, offering and managing investment funds in Australia and globally. The firm is focused on various investment strategies that aims to deliver long-term risk-adjusted returns to investors, with a focus on capital preservation. Its investment funds include Harding Loevner International Fund, Axiom International Ethical Funds, Pengana International Equities Limited, Australian Equities Fund, Emerging Companies Fund, Global Small Companies Fund, Pengana Private Equity Trust, WHEB Sustainable Impact Fund, High Conviction Equities Fund, High Conviction Property Securities Fund and Alpha Israel Fund. The Company’s subsidiaries include Pengana Holdings Pty Ltd, Pengana Capital Ltd, Pengana Investment Management Ltd, Pengana USA Holdings Inc., Lizard Overseas Fund LP and Lizard Investors LLC.
📈 Performance
Price History
-65.64%
1M
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💰 Dividends
Payouts
💰 Annual Dividend Yield*
6.60%
💰 Annual Dividend Earnings Per $1,000 invested**
$66.01
💰 Most Recent Dividend Franked Percentage Estimate
100.00%
💰 Average Dividend Franked Percentage Estimate
96.67 %
💰 Dividend reinvestment
* Based on the most recent dividend
** Calculated by multiplying the most recent dividend yield by $1,000
Dividend History
1Y
5Y
10Y
Graph
Table
Year
Yearly Dividend Earnings Per Share
Franking Estimate
2024
$0.00
0.00%
2023
$0.00
0.00%
2022
$0.20
100.00%
2021
$0.13
100.00%
2020
$0.08
100.00%
2019
$0.04
Infinity%
2018
$0.13
0.00%
2017
$0.09
100.00%
2016
$0.29
100.00%
2015
$0.15
50.00%
💵 Costs
💼
0%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$1.34
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in PCG
1
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in PCG
N/A
PCG investor breakdown
💵 Income of investors
More than 200k
100%
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
100%
🙋 Legal gender of investors
Female
Male
100%
Pearlers who invest in PCG also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
📊 Share price
$90.18 AUD
NULL AUSTRALIA
NULL BETA
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
📊 Share price
$57.36 AUD
NULL GLOBAL
NULL SMART BETA
HACK.AX was created on 2016-08-30 by BetaShares. The fund's investment portfolio concentrates primarily on theme equity. The fund aims to track the performance of an index (before fees and expenses) that provides exposure to the leading companies in the global cybersecurity sector.
📊 Share price
$9.18 AUD
IXJ.AX was created on 2001-11-13 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or smallcapitalisation stocks
📊 Share price
$126.90 AUD
NULL GLOBAL
NULL SMART BETA
ETHI.AX was created on 2017-01-05 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes a portfolio of large global stocks identified as Climate Leaders that have also passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.
📊 Share price
$12.45 AUD
NULL GLOBAL
NULL SMART BETA
NULL ETHICAL
NULL EX AUSTRALIA
Want more shares? Try these...
Perpetual Credit Income Trust is a AU-based company operating in industry. The company is headquartered in Sydney, New South Wales. The company went IPO on 2019-05-14. Perpetual Credit Income Trust (the Trust) is an Australia-based investment trust. The investment objective of the Trust is to provide investors with monthly income by investing in a diversified pool of credit and fixed income assets in accordance with the Product Disclosure Statement and the provisions of the Trust’s Constitution. The Trust invests in a portfolio of credit and fixed income assets diversified by country, asset type, credit quality, loan maturity and issuer. The company holds a portfolio of approximately 50 to 100 assets. The Investment Manager of the Trust is Perpetual Investment Management Limited.
📊 Share price
$0.97 AUD
PCK
PainChek Ltd. engages in the development and commercialisation of mobile medical device applications. The company is headquartered in Sydney, New South Wales. The company went IPO on 2012-05-01. The Company’s principal activities are development and commercialization of mobile medical device applications that provide pain assessment for individuals that are unable to communicate with their carers. The Company’s PainChek Universal is a complete point-of-care solution that combines the existing PainChek Application with the numerical rating scale (NRS). PainChek Application uses artificial intelligence and facial recognition to detect pain in those who cannot self-report. This gives a voice to those who cannot verbalize pain, whilst also driving objectivity and consistency in all assessments. For those who can self-report, PainChek Universal also includes access to the NRS, a standard used to document pain levels amongst these individuals. PainChek Universal also supports pain assessment using both tools at the point of care, for those people whose ability to communicate fluctuates.
📊 Share price
$0.03 AUD
Parabellum Resources Ltd. operates as an exploration company. The company is headquartered in Perth, Western Australia. The company went IPO on 2021-11-29. The firm is engaged in developing rare earth deposits around the world. The firm's Khotgor rare earth element (REE) Project offers exposure to an undeveloped rare earth deposit. The Khotgor REE deposit (License MV-015631) is located approximately 530 kilometers (km) south-southwest of Ulaanbaatar in the Omnogovi Aimag province of Mongolia. The license covers an area of approximately 20 square kilometers, which is relatively flat with a relief of approximately 30-40 meters. The firm owns tenure in New South Wales (NSW) across four projects, such as the Lunns Dam, Redlands-Whitbarrow and Recovery Projects in the Tottenham-Girilambone district of central-west NSW, which comprises four granted exploration licenses covering approximately 690 square kilometers; and the Obley Project in the Yeoval district of central NSW, which comprises one granted exploration license covering approximately 180 square kilometers.
📊 Share price
$0.34 AUD
Probiotec Ltd. engages in manufacture, market and distribution of over-the-counter pharmaceuticals, complementary medicines and specialty ingredients. The company is headquartered in Melbourne, Victoria. The company went IPO on 2006-11-14. The firm is engaged in the development, manufacturing, packing and sale of pharmaceuticals, consumer health and fast-moving consumer products. The firm owns over six manufacturing facilities in Australia and distributes its products both domestically and internationally. Its products are manufactured on behalf of a range of clients, including international companies. The company also owns Multipack-LJM business, a contract packer, providing packing services for a range of pharmaceutical, consumer healthcare, cosmetics, food and beverage companies. Its subsidiaries include Probiotec Pharmaceuticals Pty Ltd, Probiotec Pharma Pty Ltd, Biotech Pharmaceuticals Australia Pty Ltd, Biotech Pharmaceuticals Pty Ltd, Probiotec (NSW) Pty Ltd, Australian Dairy Proteins Pty Ltd, Milton Pharmaceuticals Pty Ltd, Willie Labs Generics Pty Ltd, South Pack Laboratories (Aust) Pty Ltd, LJM Marketing Services Pty Ltd, Multipack-LJM Pty Ltd and LJM (NSW) Pty Ltd.
📊 Share price